Refuge is a cancer immunotherapy company leveraging synthetic biology and gene engineering to unlock the full promise of cell therapies. We create cell therapies that sense their surroundings and conditionally activate or repress multiple genes simultaneously – resulting in more potent and targeted treatments beyond a single target and function.
Board of Directors
Scientific Advisory Board
Professor Stanley Qi gave a talk on gene editing and gene expression control at the 2016 Tencent WE conference in Beijing. (In Chinese)
Dr. Bing Wang gave a talk on Refuge Biotechnologies’ therapeutic platform at the 2017 Pioneers Festival in Vienna.
An Effort to Develop Safer and More Effective Immunotherapies by The Bio Report